Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation
Titel:
Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation
Auteur:
Naccarelli, Gerald V. Cappato, Riccardo Hohnloser, Stefan H. Marchlinski, Francis E. Wilber, David J. Xiang, Jim Ma, Changsheng Hess, Susanne Davies, David Wyn Fields, Larry E. Natale, Andrea
Verschenen in:
Journal of interventional cardiac electrophysiology